Valix Medical has received a US patent—10,278,820 (percutaneous valve repair and replacement)—for its heart valve repair and replacement technology. A press release reports that the company is developing transcatheter solutions for patients suffering from valvular heart disease and heart failure.
It adds that Valix Medical technology is distinguished in its approach to offer both repair and replacement treatment in one procedure, noting that “this unique toolbox approach” gives more options for interventional cardiologists to deliver the most effective therapy to this complex condition.
Eli Bar, CEO and founder of Valfix Medical, says: “It is exciting to receive this patent as it confirms our technology patentability; our technology is unique and distinct in the market. This patent granted confirms and protects our core technology and adds significant value to our stakeholders.”
Concurrently with the issuance of this patent, Valfix Medical continues to develop its patent portfolio with other patents in preparation and pending.
Source CardiovascularNews
Duc Tin clinic
Tin tức liên quan
Performance diagnostique de l’interféron gamma dans l’identification de l’origine tuberculeuse des pleurésies exsudatives
A Mixed Phenotype of Airway Wall Thickening and Emphysema Is Associated with Dyspnea and Hospitalization for Chronic Obstructive Pulmonary Disease.
Radiological Approach to Asthma and COPD-The Role of Computed Tomography.
Significant annual cost savings found with UrgoStart in UK and Germany
Thrombolex announces 510(k) clearance of Bashir catheter systems for thromboembolic disorders
Phone: (028) 3981 2678
Mobile: 0903 839 878 - 0909 384 389